Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 11.86% is 132% above its 5-year average of 5.11%, near the high end of its 5-year range (0.20%–13.55%).
11.36% above its 12-month average of 10.65%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 3.00%.
RETURN ON ASSETS (ROA)
11.86%
RETURN ON ASSETS (ROA) AVG TTM
10.65%
RETURN ON ASSETS (ROA) AVG 3Y
7.37%
RETURN ON ASSETS (ROA) AVG 5Y
5.11%
RETURN ON ASSETS (ROA) AVG 10Y
-0.39%
RETURN ON ASSETS (ROA) AVG 15Y
-8.10%
RETURN ON ASSETS (ROA) AVG 20Y
-18.24%
CURRENT VS TTM AVG
+11.36%
CURRENT VS 3Y AVG
+60.98%
CURRENT VS 5Y AVG
+132.17%
CURRENT VS 10Y AVG
+3119.91%
CURRENT VS 15Y AVG
+246.42%
CURRENT VS 20Y AVG
+165.03%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+130.74%
vs the sector median at left
Insulet Corp.
Market Cap
$9.66B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$9.91B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$9.92B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$10.14B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$10.23B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.32B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.73B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$10.85B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$11.20B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $9.66B | 11.86% | 10.65% | 7.37% | 5.11% |
| Molina Healthcare, Inc. (MOH)vs › | $9.91B | -0.04% | 5.29% | 6.08% | 6.13% |
| Henry Schein, Inc. (HSIC)vs › | $9.92B | 3.54% | 3.68% | 4.39% | 5.01% |
| Globus Medical, Inc. (GMED)vs › | $10.14B | 9.76% | 6.05% | 5.92% | 6.23% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.23B | 2.17% | -6.26% | -11.14% | 1.46% |
| The Ensign Group, Inc. (ENSG)vs › | $10.32B | 6.59% | 6.34% | 6.05% | 6.29% |
| The Cooper Companies, Inc. (COO)vs › | $10.73B | 4.50% | 3.10% | 3.02% | 7.71% |
| Align Technology, Inc. (ALGN)vs › | $10.85B | 6.44% | 6.68% | 6.69% | 12.75% |
| Universal Health Services, Inc. (UHS)vs › | $11.20B | 9.58% | 8.61% | 6.84% | 6.99% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 7.03% | 4.83% | 6.67% | 7.46% |
ROA
11.9%
ROE
26.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.75% |
| 2024-12-31 | 13.55% |
| 2023-12-31 | 7.97% |
| 2022-12-31 | 0.20% |
| 2021-12-31 | 0.82% |
| 2020-12-31 | 0.36% |
| 2019-12-31 | 1.01% |
| 2018-12-31 | 0.35% |
| 2017-12-31 | -3.29% |
| 2016-12-31 | -6.32% |
| 2015-12-31 | -26.72% |
| 2014-12-31 | -17.04% |
| 2013-12-31 | -15.62% |
| 2012-12-31 | -26.19% |
| 2011-12-31 | -27.28% |
| 2010-12-31 | -39.15% |
| 2009-12-31 | -46.34% |
| 2008-12-31 | -84.95% |
| 2007-12-31 | -40.95% |
| 2006-12-31 | -62.92% |
| 2005-12-31 | -128.85% |
| 2004-12-31 | -50.96% |
| 2003-12-31 | -240.84% |
| 2002-12-31 | -71.84% |
